The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data
Abstract
Background The WHO Access, Watch, and Reserve (AWaRe) antibiotic classification framework aims to balance appropriate access to antibiotics and stewardship. We aimed to identify how patterns of antibiotic consumption in each of the AWaRe categories changed across countries over 15 years. Methods Antibiotic consumption was classified into Access, Watch, and Reserve categories for 76 countries between 2000, and 2015, using quarterly national sample survey data obtained from IQVIA. We measured the proportion of antibiotic use in each category, and calculated the ratio of Access antibiotics to Watch antibiotics (access-to-watch index), for each country. Findings Between 2000, and 2015, global per-capita consumption of Watch antibiotics increased by 90·9% (from 3·3 to 6·3 defined daily doses per 1000 inhabitants per day [DIDs]) compared with an increase of 26·2% (from 8·4 to 10·6 DIDs) in Access antibiotics. The increase in Watch antibiotic consumption was greater in low-income and middle-income countries (LMICs; 165·0%; from 2·0 to 5·3 DIDs) than in high-income countries (HICs; 27·9%; from 6·1 to 7·8 DIDs). The access-to-watch index decreased by 38·5% over the study period globally (from 2·6 to 1·6); 46·7% decrease in LMICs (from 3·0 to 1·6) and 16·7% decrease in HICs (from 1·8 to 1·5), and 37 (90%) of 41 LMICs had a decrease in their relative access-to-watch consumption. The proportion of countries in which Access antibiotics represented at least 60% of their total antibiotic consumption (the WHO national-level target) decreased from 50 (76%) of 66 countries in 2000, to 42 (55%) of 76 countries in 2015. Interpretation Rapid increases in Watch antibiotic consumption, particularly in LMICs, reflect challenges in antibiotic stewardship. Without policy changes, the WHO national-level target of at least 60% of total antibiotic consumption being in the Access category by 2023, will be difficult to achieve. The AWaRe framework is an important measure of the effort to combat antimicrobial resistance and to ensure equal access to effective antibiotics between countries. Funding US Centers for Disease Control and Prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The predominance of Access-group antibiotics suggests partial alignment with stewardship-oriented prescribing 28,29,31,32 , whereas the proportion of Watch-group use indicates potential scope for optimization 31-33 .”
From Outpatient Antibiotic Prescribing and Stewardship in South India: AnalysisUsing WHO/INRUD Indicators and AWaRe Classification (2026) · cites this paper as [29]
Citations
Cites
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Self-citationThe threat of antimicrobial resistance in developing countries: causes and control strategies
Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0208-x · Cited by 1,315
Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
Shapiro, D. J., Hicks, L. A., Pavia, A. T., & Hersh, A. L. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt301 · Cited by 476
Hsia, Y., Lee, B. R., Versporten, A., Yang, Y., Bielicki, J. A., Jackson, C., Newland, J. G., Goossens, H., Magrini, N., Sharland, M., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30071-3 · Cited by 350
Self-citationVersporten, A., Bolokhovets, G., Ghazaryan, L., Abilova, V., Pyshnik, G., Spasojevic, T., Korinteli, I., Raka, L., Kambaralieva, B., Čizmović, L., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70071-4 · Cited by 290
Goossens, H., Ferech, M., Coenen, S., Stephens, P., & European Surveillance of Antimicrobial Consumption Project Group (2007) · Clinical Infectious Diseases · doi:10.1086/512810 · Cited by 226
Hsia, Y., Sharland, M., Jackson, C., Wong, I. C. K., Magrini, N., & Bielicki, J. A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30547-4 · Cited by 206
Self-citationMendelson, M., Røttingen, J., Gopinathan, U., Hamer, D. H., Wertheim, H. F. L., Basnyat, B., Butler, C., Tomson, G. B., & Balasegaram, M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00547-4 · Cited by 205
Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index
Klein, E. Y., Tseng, K. K., Pant, S., & Laxminarayan, R. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001315 · Cited by 178
Self-citationGebretekle, G. B., Mariam, D. H., Abebe, W., Amogne, W., Tenna, A., Fenta, T. G., Libman, M., Yansouni, C. P., & Semret, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208447 · Cited by 133
Cited by
Sorted by citations
Items 201–300 of 501
Labi, A.-K., Kartey, B. S., Hedidor, G. K., Nuertey, B. D., Kodjoe, E., Vanderpuije, L. N. O., & Obeng‐Nkrumah, N. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad025 · Cited by 12
Enhancing pharmaceutical removal in a full-scale constructed wetland with effluent recirculation
Melián, J. A. H., Guedes-Alonso, R., Tite-Lezcano, J. C., Sosa‐Ferrera, Z., & Santana‐Rodríguez, J. J. (2023) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2023.111167 · Cited by 11
Sono, T. M., Marković‐Peković, V., & Godman, B. (2023) · Advances in Human Biology · doi:10.4103/aihb.aihb_128_23 · Cited by 13
Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype
Riester, O., Kaiser, L., Laufer, S., & Deigner, H. (2024) · Advanced Science · doi:10.1002/advs.202308806 · Cited by 11
Mustafa, Z. U., Khan, A. H., Salman, M., Harun, S. N., Meyer, J. C., & Godman, B. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae193 · Cited by 12
Cheng, N., Wang, J., Cheng, H., & Wang, X. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121212 · Cited by 11
Maryam, S., Saleem, Z., Haseeb, A., Qamar, M. U., Amir, A., Abuhussain, S. S. A., Imam, M. T., Afzal, S., Meyer, J. C., Mudenda, S., et al. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s531874 · Cited by 15
Kakkar, A. K., Shafiq, N., Sahni, N., Mohindra, R., Kaur, N., Gamad, N., Panditrao, A., Kondal, D., Malhotra, S., Kumar, P. M., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10020200 · Cited by 11
Dechasa, M., Chelkeba, L., Jorise, A., Sefera, B., & Melaku, T. (2022) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-022-00490-4 · Cited by 10
Yang, H., Zu, X., Lin, J., Wu, M., Chen, L., Jiang, X., Xie, Z., Ye, T., Yang, D., & Qiu, X. (2023) · Applied Energy · doi:10.1016/j.apenergy.2023.121568 · Cited by 11
Belachew, S. A., Hall, L., & Selvey, L. A. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09819-4 · Cited by 11
Boni, S., Marin, G. H., Campaña, L., Marín, L., Patron, S. R., Marin, G., Gabriel, F., Corso, A. C., Garay, V., & Limeres, M. (2022) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2022/3924212 · Cited by 11
Zhao, J., Xu, L., Lv, L., Wang, L., Wang, X., Liang, C., Wang, C., Qiu, Y., & Pei, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21219 · Cited by 11
Debnath, F., De, R. G., Chakraborty, D., Majumdar, A. S., Mukhopadhyay, S., Sarkar, M. D., Singh, T., Patra, S. K., Saha, S., Rehman, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78111-0 · Cited by 10
Sheikh, S., Saleem, Z., Afzal, S., Qamar, M. U., Raza, A. A., Naqvi, S. Z. H., Al‐Rawi, M. B. A., & Godman, B. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1469766 · Cited by 15
Mudenda, S., Lubanga, A. F., Jamshed, S. Q., Biemba, B., Sakala, R., Chiyabi, M., Kavubya, L., Milambo, L. T., Bumbangi, F. N., Chizimu, J. Y., et al. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s509522 · Cited by 10
Low-temperature one-step synthesis of cerium doped ZnO nanoparticles for antibacterial application
Zhang, H., Zhou, W., Xiang, Y., Chen, K., Ao, Z., Gao, Y., Wang, P., Hu, Z.-T., Xu, W., & Shen, Z. (2025) · Chemical Engineering Science · doi:10.1016/j.ces.2025.121628 · Cited by 10
Desai, V., Kumar, S., Patel, B. R., Patel, S. N., Patadiya, H. H., Asawa, D., Pathan, M. S. H., & Haque, M. (2025) · Cureus · doi:10.7759/cureus.82064 · Cited by 11
Renggli, L., Gasser, M., Plüss-Suard, C., Harbarth, S., & Kronenberg, A. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.11.006 · Cited by 10
Guedes-Alonso, R., Melián, J. A. H., Sánchez-Suárez, F., Díaz, V., Sosa‐Ferrera, Z., & Santana‐Rodríguez, J. J. (2022) · Water · doi:10.3390/w14152340 · Cited by 10
Mustafa, Z. U., Manzoor, M. N., Shahid, A., Salman, M., Hayat, K., Yasmin, K., Baraka, M. A., Mathew, S., Kanwal, M., Parveen, S., et al. (2022) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s376664 · Cited by 10
Hennessey, M., Ebata, A., Samanta, I., Mateus, A., Arnold, J.-C., Day, D., Gautham, M., & Alarcón, P. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281188 · Cited by 10
The Challenge of Outpatient Antibiotic Stewardship
Sayood, S. J., & Durkin, M. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.12996 · Cited by 10
Saksena, R., Parida, A., Jain, M., & Gaind, R. (2025) · Access Microbiology · doi:10.1099/acmi.0.000638.v4 · Cited by 10
Multidrug-Resistant Infections in the Developing World
Singh, P., & Holmen, J. (2021) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2021.09.003 · Cited by 10
Alshareef, H. M., Alanazi, A., Alatawi, N., Eleshmawy, N., & Ali, M. A. S. (2022) · American Journal of Infection Control · doi:10.1016/j.ajic.2022.07.009 · Cited by 9
Mo, Y., Ding, Y., Cao, Y., Hopkins, J., Ashley, E. A., Waithira, N., Wannapinij, P., Lee, S. J., Ling, C., Hamers, R. L., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.19210.2 · Cited by 9
Zewdie, S., Andargie, A., Yayehrad, A. T., Melkie, M., Ayenew, W. A., Zewudie, M., Mulat, S., Bitew, B. E., Zewudie, S., Meharie, B. G., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01808-5 · Cited by 23
Abdullah, S., Saleem, Z., Godman, B., Hashmi, F. K., Haseeb, A., Al‐Rawi, M. B. A., Qamar, M. U., & Sharland, M. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2511958 · Cited by 14
Self-citationAntimicrobial Resistance Traits and Resistance Mechanisms in Bacterial Pathogens
Paul, D., Verma, J., Banerjee, A., Konar, D., & Das, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-3120-7_1 · Cited by 9
Zhang, X., Liu, S., Sun, H., Huang, K., & Ye, L. (2022) · Journal of Environmental Sciences · doi:10.1016/j.jes.2022.04.021 · Cited by 9
Li, Y., Liu, L.-H., Jian, Z., Li, P.-H., Jin, X., Li, H., & Wang, K. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-023-00711-z · Cited by 9
Gautham, M., Bhattacharyya, S., Maity, S., Roy, M. B., Balasubramaniam, P., Ebata, A., & Bloom, G. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-076616 · Cited by 9
Konda, S., Nagendla, N. K., Williams, M., & Mudiam, M. K. R. (2024) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2024.100420 · Cited by 10
Yun, I. J., Park, H. J., Chae, J., Heo, S., Kim, Y. C., Kim, B., & Choi, J. Y. (2024) · Infection and Chemotherapy · doi:10.3947/ic.2024.0013 · Cited by 9
Makwela, A. B., Grootboom, W., Abraham, V., Witika, B. A., Godman, B., & Skosana, P. (2023) · Antibiotics · doi:10.3390/antibiotics12020275 · Cited by 9
Nagassar, R. P., Jalim, N., Mitchell, A., Harrinanan, A., Mohammed, A., Dookeeram, D. K., Marín, D., Giangreco, L., Lichtenberger, P. K., & Marin, G. H. (2023) · Antibiotics · doi:10.3390/antibiotics12030466 · Cited by 8
Gagliotti, C., Cangini, A., Cas, R. D., Ippoliti, I., Trotta, F., & Fortinguerra, F. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae110 · Cited by 8
Xu, X., Yang, C., Zou, L., Leng, J., Wang, N., & Zhang, J. (2024) · Environmental Monitoring and Assessment · doi:10.1007/s10661-024-13149-1 · Cited by 8
Sono, T. M., Schellack, N., & Godman, B. (2024) · Advances in Human Biology · doi:10.4103/aihb.aihb_124_24 · Cited by 10
Song, H., Liu, X., Zou, K., Li, H., Fei, H., Huang, L., Yu, Q., & Zhang, L. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01391-5 · Cited by 8
An assessment of antimicrobial resistance national action plans and their impact on antibiotic use
O’Neill, E., Wei, J., Machado, S., Galárraga, O., & Papanicolas, I. N. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2025-020536 · Cited by 8
Cheng, L., Li, H., Luo, C., Zhang, Y., Cheng, K., Wang, S., & Hu, Z. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.172299 · Cited by 8
Allel, K., Goscé, L., Rafael Araos, B., Toro, D., Catterina Ferreccio, R., Munita, J. M., Undurraga, E. A., & Panovska‐Griffiths, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-17598-x · Cited by 8
Ekuma, A. E., Onukak, A. E., Udoette, S. B., Versporten, A., Pauwels, I., & Oduyebo, O. O. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.46.80.33027 · Cited by 8
Romo-Castillo, H. F., & Pazin‐Filho, A. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.11.001 · Cited by 8
Saxena, M., Kushwaha, J. P., Kulshreshtha, S., Kaur, G., & Singh, N. (2022) · Chemistry Africa · doi:10.1007/s42250-022-00365-w · Cited by 8
Mthombeni, T. C., Burger, J. R., Lubbe, M. S., & Julyan, M. (2022) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v37i1.463 · Cited by 8
Chevarin, C., Xu, Z., Martín, L., Robin, F., Beyrouthy, R., Colombel, J., Sulakvelidze, A., Ng, S. C., Bonnet, R., Buisson, A., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2431645 · Cited by 7
Bindel, L. J., & Seifert, R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04121-y · Cited by 7
Maksane, N., Langfeld, K., Bhaskar, J. P., Sadhu, S., & van Hasselt, J. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004558 · Cited by 10
Sefah, I. A., Chetty, S., Yamoah, P., & Bangalee, V. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329541 · Cited by 8
Hopkins, J., Lee, S. J., Waithira, N., Painter, C., Ling, C. L., Roberts, T., Miliya, T., Obeng‐Nkrumah, N., Opintan, J. A., Abbeyquaye, E. P., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101228 · Cited by 8
Chen, Y., Zhang, Z., Chen, Y., Zhou, S., Deng, Q., & Wang, S. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00641c · Cited by 7
Antimicrobial drug consumption in the Russian Federation (2008–2022): pharmacoepidemiological study
Gomon, Y. М., Колбин, А. С., Arepeva, M. A., Kalyapin, А. А., Balykina, Y. Е., Kurylev, A. A., Kuzmenkov, A. Y., & Kozlov, R. S. (2023) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2023.4.395-400 · Cited by 7
Aboderin, A. O., Amfoabegyi, S., Awopeju, A. T. O., Bahrami‐Hessari, M., Garchie, E. I. A., Gill, M. J., Karikari, A. B., Kirby, A., Makanjuola, O. B., Mutiu, B. P., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00330-9 · Cited by 8
Louca, S. (2025) · iScience · doi:10.1016/j.isci.2024.111712 · Cited by 7
Wushouer, H., Hu, L. T., Zhou, Y., Yang, Y., Du, K., Deng, Y., Yan, Q., Yang, X., Chen, Z., Zheng, B., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11070957 · Cited by 7
Long, Z., Guo, T., Chen, C., Zhang, G., & Zhu, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1210790 · Cited by 7
Wang, B., Geng, M., Li, M., Wang, X., Gan, H., Tang, Y., Yang, Q., Liu, Y., Yang, X., Wang, S., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115514 · Cited by 7
Elhajji, F. D., Abuhasheesh, S., Rusasi, A. A., & Aldeyab, M. A. (2023) · Antibiotics · doi:10.3390/antibiotics12111576 · Cited by 7
Mustafa, Z. U., Batool, A., Ibrar, H., Salman, M., Khan, Y. H., Mallhi, T. H., Meyer, J. C., Godman, B., & Moore, C. E. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2299387 · Cited by 7
Bezerra, V. S., Bedor, D. C. G., OLIVEIRA, D. E., SILVA, R. D., GOMES, G. M., LAVOR, A. L., Araújo, L. C., GUERRA, D. M., BARBOSA, V. X., & de Santana, D. P. (2021) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2021.122.0551 · Cited by 7
Peddireddy, M., Mahin, J., Uppu, A., & Padi, S. S. V. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i41b32339 · Cited by 6
“15 with second and third generation cephalosporins, fluoroquinolones, and macrolides contributing the most [3,35,38-40].”
BackgroundRani, J., Saha, S., Ferdous, F., & Rahman, M. A. (2024) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2024.102587 · Cited by 6
Kizito, M., Lalitha, R., Kajumbula, H., Muhumuza, R., Kintu, M. G., Muyanja, D., & Byakika‐Kibwika, P. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae204 · Cited by 6
Southeast‑Asian landscape of antimicrobial resistance research (2014–2024): A bibliometric analysis
Borromeo, A. S., Manaloto, A. M., & Antonio, R. P. (2025) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2025.09.004 · Cited by 7
Qu, Q., Wang, S., & Hu, X. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c09538 · Cited by 6
Can amoxicillin be detected in the aquatic environment? A critical assessment
Hernández, F. J., Botero-Coy, A. M., Bijlsma, L., & Fabregat‐Safont, D. (2026) · Environment International · doi:10.1016/j.envint.2026.110258 · Cited by 6
Antibiotic use in public hospitals in Vietnam between 2018 and 2022: a retrospective study
Dat, V. Q. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087322 · Cited by 6
Oda, K., Okamoto, S., Iwanaga, E., & Nakata, H. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.08.025 · Cited by 6
Achieving sustainable access to antibiotics is more than just a last mile challenge
Balasegaram, M., & Tellez, V. M. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01083-5 · Cited by 6
Clinic Characteristics and Antibiotic Prescribing for Acute Respiratory Infections in Japan
Aoyama, R., Tsugawa, Y., Ishikane, M., Kitajima, K., Sato, D., & Miyawaki, A. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.40406 · Cited by 6
Pei, X., Zhang, N., Chen, Y., Miao, S., Fu, H., Zhu, Q., Dai, Z., Chi, Y., Hu, L., Jin, R., et al. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113198 · Cited by 6
Multigenerational toxicity effects and impact of antibiotics exposed to duckweed, Lemna minor
Alfarsi, A., Werid, G. M., Kumar, A., & Nugegoda, D. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.179324 · Cited by 6
Phuong, T. N. T., Vu, H. T. T., Minh, A. H., Ho, A. M., Sefah, I. A., Godman, B., & Meyer, J. C. (2025) · Antibiotics · doi:10.3390/antibiotics14070709 · Cited by 6
Baetselier, I. D., Vuylsteke, B., Cuylaerts, V., Cuer, B., Yaya, I., Mensah, E., Dah, E. T. T., Anoma, C., Koné, A., Diandé, S., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac615 · Cited by 6
Yang, C., Ye, D., Yan, K., Xiang, C., Liu, S., Gu, J., Liu, Y., & Fang, Y. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2199153 · Cited by 6
Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting
Vlak, I., Samardžić, I., Marinović, I., Bušić, N., & Vrca, V. B. (2023) · Pharmacy · doi:10.3390/pharmacy11020068 · Cited by 6
Ueda, J. M., Milho, C., Heleno, S. A., Soria-López, A., Carpena, M., Alves, M. J., Pires, T. C. S. P., Prieto, M. A., Simal‐Gándara, J., Calhelha, R. C., et al. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230410095155 · Cited by 6
Jetty, P., Gaddam, S., & Padi, S. S. V. (2023) · Asian Journal of Research in Infectious Diseases · doi:10.9734/ajrid/2023/v13i4271 · Cited by 7
Sefah, I. A., Nyamadi, D. M., Kurdi, A. B., Bugri, A. A., Kerr, F., Yamoah, P., Pichierri, G., & Godman, B. (2023) · Hospital Practice · doi:10.1080/21548331.2023.2241344 · Cited by 7
A six years trend analysis of systemic antibiotic consumption in Northwest Ethiopia
Abejew, A. A., Wubetu, G. Y., & Fenta, T. G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0290391 · Cited by 8
Mustafa, Z. U., Khan, A. H., Salman, M., Harun, S. N., Meyer, J. C., & Godman, B. (2024) · Drugs & Therapy Perspectives · doi:10.1007/s40267-024-01059-8 · Cited by 7
Charani, E., Dlamini, S. K., Koch, A. S., Singh, S. K., Hodes, R., Laxminarayan, R., Batheja, D., Ramugondo, E. L., Mukherjee, A. S., & Mendelson, M. (2024) · Wellcome Open Research · doi:10.12688/wellcomeopenres.20193.1 · Cited by 7
Self-citationSelf‐prescribing of antibiotics by patients seeking care in Indian emergency departments
Blanchard, J., Solaipandian, M., John, E. B., Pandith, M., Jeo, B., Saji, S., Kumar, A., May, L. S., Davey, K., Douglass, K. A., et al. (2021) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12432 · Cited by 6
Kaupitwa, C. J., Nowaseb, S., Godman, B., & Kibuule, D. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2108404 · Cited by 6
Adekanmbi, A. O., Adesola, R. O., Adeyemi, A. O., & Mbionwu, C. C. (2023) · Infectious diseases · doi:10.5772/intechopen.113967 · Cited by 5
Afzal, S., Bajwa, M., Ahmed, N., Jabeen, J., Haroon, M. S., Mushtaq, R. M. Z., & Saleem, Z. (2025) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-025-01521-w · Cited by 7
Kurdi, A. B., Hasan, A. J., Hassan, A., He, Y., Darweesh, O., M-Amen, K., Baker, K., Karwi, H., & Godman, B. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s533590 · Cited by 5
Devi, A., Sharma, V. K., Shrivastav, D., & Singh, S. (2025) · Environmental Monitoring and Assessment · doi:10.1007/s10661-025-14786-w · Cited by 5
Hassan, A., Rehman, N. U., Maqbool, S., & Arif, M. (2025) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2025.2450017 · Cited by 9
Makiko, F., Kalungia, A. C., Kampamba, M., Mudenda, S., Schellack, N., Meyer, J. C., Bumbangi, F. N., Okorie, M., Banda, D. C., Munkombwe, D., et al. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf085 · Cited by 5
Ye, D., Yang, C., Ji, W., Zheng, J. H., Zhang, J., Xue, R., Gu, J., Chen, M., Yan, K., & Liu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739960 · Cited by 5
Synthesis and Pharmacological Characterization of Metronidazole-Oxadiazole Derivatives.
Mohammed, M. O., & Haj, N. Q. (2023) · PubMed Central · doi:10.30476/ijms.2022.95534.2691 · Cited by 5
Андреевна, Б. Ю., Rachina, S. A., Kozlov, R. S., Kuleshov, V. G., Vasilieva, I. S., Kurkova, A. A., Николаевна, Б. Е., Елохина, Е. В., Попов, Д. А., Portnyagina, U. S., et al. (2023) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2023.2.150-158 · Cited by 6
Antibiotic and antifungal use in paediatric departments at three academic hospitals in South Africa
Moore, D. P., Chetty, T., Pillay, A., Karsas, M., Cloete, J., Balakrishna, Y., Reddy, T., Archary, M., van Kwawegen, A., Thomas, R., et al. (2023) · IJID Regions · doi:10.1016/j.ijregi.2023.12.004 · Cited by 5
Gupta, M., Bansal, A., Khan, F., Sagar, V., Suri, V., Bansal, A., Guglani, V., Mahajan, V., Pandit, S., Singh, G., et al. (2024) · The Indian Journal of Medical Research · doi:10.25259/ijmr_2080_22 · Cited by 4
Lubanga, A. F., Bwanali, A. N., Kamanga, W., Kathewera, B. S., Makole, T., Mpinganjira, S., Mudenda, S., Mitambo, C., Cho, Y., Yeum, D., et al. (2024) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s487530 · Cited by 5
The impact of health and technology shifts on antibiotic use among the elderly in Thailand
Prasit, N., Phimha, S., Nonthamat, A., Nilnate, N., Nidthumsakul, N., & Sresutham, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-89040-x · Cited by 5
Metadata
- Authors
- Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R.
- Affiliations
- Center for Disease Dynamics, Economics & Policy (US)
- St George's, University of London (GB)
- Washington University in St. Louis (US)
- Corresponding author
- Klein, Eili Y
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 21
- Issue
- 1
- Pages
- 107-115
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W3044776476
- Cited by
- 500
- References
- 26
- Citations by year
- 2026: 61 · 2025: 95 · 2024: 110 · 2023: 94 · 2022: 78 · 2021: 58
- FWCI
- 34.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- HAL (submittedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- antibiotic use, AWaRe classification, antibiotic access, antibiotic stewardship, pharmaceutical sales data, Watch antibiotics, low- and middle-income countries, high-income countries, defined daily doses, antimicrobial resistance, cross-national comparison
- MeSH terms
- Antimicrobial Stewardship, Anti-Bacterial Agents, Commerce, Developing Countries, Drug Utilization, Pharmaceutical Preparations, Forecasting, Humans, World Health Organization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review